I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Fisseha, Nahome
9
results:
Online X
Search for persons
X
Format
Online (9)
Mediatypes
Articles (Online) (7)
OpenAccess-fulltext (2)
Sorted by: Relevance
Sorted by: Year
?
1
Continuous subcutaneous foslevodopa/foscarbidopa infusion f..:
Fung, Victor S.C.
;
Aldred, Jason
;
Arroyo, Martha P.
...
Clinical Parkinsonism & Related Disorders. 10 (2024) - p. 100239 , 2024
Link:
https://doi.org/10.1016/..
?
2
Tilavonemab in early Alzheimer's disease: results from a ph..:
Florian, Hana
;
Wang, Deli
;
Arnold, Steven E
...
Brain. 146 (2023) 6 - p. 2275-2284 , 2023
Link:
https://doi.org/10.1093/..
?
3
Safety of Foslevodopa/Foscarbidopa During Optimization and ..:
Kern, Drew
;
Dashtipour, Khashayar
;
Aldred, Jason
...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023
Link:
https://doi.org/10.1212/..
?
4
Efficacy and Safety of Foslevodopa/Foscarbidopa Versus Oral..:
Facheris, Maurizio
;
Robieson, Weining
;
Fisseha, Nahome
.
Neurology. 96 (2021) 15_supplement - p. , 2021
Link:
https://doi.org/10.1212/..
?
5
Baseline amyloid and tau PET imaging characteristics in the..:
Wooten, Dustin W.
;
Guo, Qi
;
Jin, Ziyi
...
Alzheimer's & Dementia. 17 (2021) S4 - p. , 2021
Link:
https://doi.org/10.1002/..
?
6
Efficacy and safety of foslevodopa/foscarbidopa versus oral..:
Facheris, Maurizio
;
Robieson, Weining
;
Fisseha, Nahome
.
Journal of the Neurological Sciences. 429 (2021) - p. 119569 , 2021
Link:
https://doi.org/10.1016/..
?
7
Identifying predictive factors of patient dropout in Alzhei..:
Crimin, Kimberly
;
Allen, Patricia J
;
Abba, Iman
...
Alzheimer's & Dementia. 17 (2021) S9 - p. , 2021
Link:
https://doi.org/10.1002/..
?
8
Tilavonemab in early Alzheimer's disease: results from a ph..:
Florian, Hana
;
Wang, Deli
;
Arnold, Steven E
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232284/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
9
Safety and efficacy of tilavonemab in progressive supranucl..:
Höglinger, Günter U
;
Litvan, Irene
;
Mendonca, Nuno
...
qt6bc7k734. , 2021
Link:
https://escholarship.org..
1-9